Description
Cagrilintide is a long-acting amylin analog with published obesity and diabetes trial data, including combination development programs with semaglutide.
What it is
Cagrilintide is a long-acting amylin analog in active metabolic-disease development, with published obesity/diabetes trial data and ongoing late-stage programs.
Mechanism snapshot
- Targets amylin-pathway signaling involved in appetite and energy-balance regulation.
- Investigated as monotherapy and in coadministration with semaglutide (CagriSema) for weight and glycemic endpoints.
- Studied for efficacy durability, tolerability, and cardiometabolic-risk impact.
Research programs
- Phase 1b and phase 2 weight-management trials.
- Late-stage registry programs in obesity and type 2 diabetes populations.
- Comparative and long-horizon maintenance-of-effect investigations.
Limitations
- Full late-stage synthesis is still evolving and status can change.
- Comparative efficacy interpretation depends on protocol and population context.
- Long-term safety and indication-specific labeling remain development-dependent.
Selected references
- Once-weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double-blind, placebo-controlled and active-controlled, dose-finding phase 2 trial - PubMed 2021
- Safety, tolerability, pharmacokinetics, and pharmacodynamics of concomitant administration of multiple doses of cagrilintide with semaglutide 2?4 mg for weight management: a randomised, controlled, phase 1b trial - PubMed 2021
- Coadministered Cagrilintide and Semaglutide in Adults with Overweight or Obesity - PubMed 2025
- REDEFINE 1: A Research Study to See How Well CagriSema Helps People With Excess Body Weight Lose Weight (NCT05567796) - ClinicalTrials.gov Status snapshot
- REDEFINE 4: Long-term CagriSema Weight Loss and Maintenance Study (NCT07011667) - ClinicalTrials.gov Status snapshot
Ordering
Add this item to your cart, submit your shipping details at checkout, and wait for your order confirmation. Interac e-Transfer instructions are sent after the order request is received.


